dr. clarke on available egfr tkis in frontline treatment of egfr nsclc
Published 5 years ago • 116 plays • Length 1:52Download video MP4
Download video MP3
Similar videos
-
0:30
copy of dr. clarke compares tkis in egfr nsclc
-
9:31
frontline treatment for egfr nsclc
-
1:23
dr. kujtan on frontline therapy for egfr-positive nsclc
-
8:11
advances in frontline therapy for egfr nsclc
-
5:18
frontline therapy for egfr plus nsclc: osimertinib’s impact
-
6:41
egfr-positive nsclc: treatment at progression
-
2:45
activity of egfr tkis in patients with nsclc with uncommon egfr mutations
-
6:51
osimertinib as frontline therapy in egfr-positive nsclc
-
1:57
dr. piotrowska on treatment for egfr-mutant nsclc
-
1:37
dr. konduri on treatment options for patients with egfr-mutant nsclc
-
5:54
frontline alk, egfr inhibition in non-small cell lung cancer
-
4:09
frontline afatinib in egfr-mutant nsclc
-
1:36
comment: front-line osimertinib significantly lengthens overall survival in egfr-mutation positi...
-
0:59
dr. west on emerging changes in the field of egfr-mutant nsclc
-
5:52
treatment of egfr nsclc after osimertinib
-
7:51
nsclc: egfr inhibition and resistance mechanisms
-
4:59
egfr therapy in nsclc
-
5:13
case 2: frontline therapy in egfr-mutated lung cancer
-
1:47
dr. west on fda approval of afatinib in nsclc with rare egfr mutations